Table of Contents

1 Study Coverage

• 1.1 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Insulin Pump
  • 1.2.3 Continuous Glucose Monitors (CGM)
• 1.3 Market by Application
  • 1.3.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Child
  • 1.3.3 Adult
  • 1.3.4 Elderly
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Estimates and Forecasts 2017-2028
• 2.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Estimates and Forecasts 2017-2028
• 2.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Region: 2017 VS 2021 VS 2028
• 2.4 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Region
  • 2.4.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Region (2017-2022)
  • 2.4.2 Global Sales Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) by Region (2023-2028)
• 2.5 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Region
  • 2.5.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Region (2017-2022)
  • 2.5.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Region (2023-2028)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Manufacturers
  • 3.1.1 Global Top Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturers by Sales (2017-2022)
  • 3.1.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Manufacturers (2017-2022)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) in 2021
• 3.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Manufacturers
  • 3.2.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Manufacturers (2017-2022)
  • 3.2.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Manufacturers (2017-2022)
  • 3.2.3 Global Top 10 and Top 5 Companies by Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue in 2021
• 3.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Price by Manufacturers (2017-2022)
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Type
  • 4.1.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Historical Sales by Type (2017-2022)
  • 4.1.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Forecasted Sales by Type (2023-2028)
  • 4.1.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Type (2017-2028)
• 4.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Type
  • 4.2.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Historical Revenue by Type (2017-2022)
  • 4.2.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Forecasted Revenue by Type (2023-2028)
  • 4.2.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Type (2017-2028)
• 4.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Price by Type
  • 4.3.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Price by Type (2017-2022)
  • 4.3.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Price Forecast by Type (2023-2028)

5 Market Size by Application

• 5.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Application
  • 5.1.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Historical Sales by Application (2017-2022)
  • 5.1.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Forecasted Sales by Application (2023-2028)
  • 5.1.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Market Share by Application (2017-2028)
• 5.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Application
  • 5.2.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Historical Revenue by Application (2017-2022)
  • 5.2.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Forecasted Revenue by Application (2023-2028)
  • 5.2.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue Market Share by Application (2017-2028)
• 5.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Price by Application
  • 5.3.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Price by Application (2017-2022)
  • 5.3.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Price Forecast by Application (2023-2028)

6 North America

• 6.1 North America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size by Type
  • 6.1.1 North America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Type (2017-2028)
  • 6.1.2 North America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Type (2017-2028)
• 6.2 North America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size by Application
  • 6.2.1 North America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Application (2017-2028)
  • 6.2.2 North America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Application (2017-2028)
• 6.3 North America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size by Country
  • 6.3.1 North America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Country (2017-2028)
  • 6.3.2 North America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Country (2017-2028)
  • 6.3.3 United States
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size by Type
  • 7.1.1 Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Type (2017-2028)
  • 7.1.2 Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Type (2017-2028)
• 7.2 Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size by Application
  • 7.2.1 Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Application (2017-2028)
  • 7.2.2 Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Application (2017-2028)
• 7.3 Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size by Country
  • 7.3.1 Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Country (2017-2028)
  • 7.3.2 Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Country (2017-2028)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size by Type
  • 8.1.1 Asia Pacific Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Type (2017-2028)
  • 8.1.2 Asia Pacific Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Type (2017-2028)
• 8.2 Asia Pacific Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size by Application
  • 8.2.1 Asia Pacific Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Application (2017-2028)
  • 8.2.2 Asia Pacific Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Application (2017-2028)
• 8.3 Asia Pacific Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size by Region
  • 8.3.1 Asia Pacific Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Region (2017-2028)
  • 8.3.2 Asia Pacific Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Region (2017-2028)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 China Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia

9 Latin America

• 9.1 Latin America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size by Type
  • 9.1.1 Latin America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Type (2017-2028)
  • 9.1.2 Latin America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Type (2017-2028)
• 9.2 Latin America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size by Application
  • 9.2.1 Latin America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Application (2017-2028)
  • 9.2.2 Latin America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Application (2017-2028)
• 9.3 Latin America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size by Country
  • 9.3.1 Latin America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Country (2017-2028)
  • 9.3.2 Latin America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Country (2017-2028)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size by Type
  • 10.1.1 Middle East and Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Type (2017-2028)
  • 10.1.2 Middle East and Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Type (2017-2028)
• 10.2 Middle East and Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size by Application
  • 10.2.1 Middle East and Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Application (2017-2028)
  • 10.2.2 Middle East and Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Application (2017-2028)
• 10.3 Middle East and Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Size by Country
  • 10.3.1 Middle East and Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales by Country (2017-2028)
  • 10.3.2 Middle East and Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Country (2017-2028)
  • 10.3.3 Turkey
  • 10.3.4 Saudi Arabia

11 Company Profiles

• 11.1 Abbott Laboratories
  • 11.1.1 Abbott Laboratories Corporation Information
  • 11.1.2 Abbott Laboratories Overview
  • 11.1.3 Abbott Laboratories Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.1.4 Abbott Laboratories Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Abbott Laboratories Recent Developments
• 11.2 Dexcom
  • 11.2.1 Dexcom Corporation Information
  • 11.2.2 Dexcom Overview
  • 11.2.3 Dexcom Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.2.4 Dexcom Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Dexcom Recent Developments
• 11.3 GlySens Incorporated
  • 11.3.1 GlySens Incorporated Corporation Information
  • 11.3.2 GlySens Incorporated Overview
  • 11.3.3 GlySens Incorporated Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.3.4 GlySens Incorporated Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 GlySens Incorporated Recent Developments
• 11.4 Insulet Corp
  • 11.4.1 Insulet Corp Corporation Information
  • 11.4.2 Insulet Corp Overview
  • 11.4.3 Insulet Corp Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.4.4 Insulet Corp Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Insulet Corp Recent Developments
• 11.5 Johnson & Johnson
  • 11.5.1 Johnson & Johnson Corporation Information
  • 11.5.2 Johnson & Johnson Overview
  • 11.5.3 Johnson & Johnson Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.5.4 Johnson & Johnson Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Johnson & Johnson Recent Developments
• 11.6 Medtronic
  • 11.6.1 Medtronic Corporation Information
  • 11.6.2 Medtronic Overview
  • 11.6.3 Medtronic Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.6.4 Medtronic Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Medtronic Recent Developments
• 11.7 Meiqi Medical Equipment
  • 11.7.1 Meiqi Medical Equipment Corporation Information
  • 11.7.2 Meiqi Medical Equipment Overview
  • 11.7.3 Meiqi Medical Equipment Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.7.4 Meiqi Medical Equipment Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Meiqi Medical Equipment Recent Developments
• 11.8 Microport
  • 11.8.1 Microport Corporation Information
  • 11.8.2 Microport Overview
  • 11.8.3 Microport Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.8.4 Microport Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Microport Recent Developments
• 11.9 Roche
  • 11.9.1 Roche Corporation Information
  • 11.9.2 Roche Overview
  • 11.9.3 Roche Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.9.4 Roche Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Roche Recent Developments
• 11.10 Senseonics Holdings
  • 11.10.1 Senseonics Holdings Corporation Information
  • 11.10.2 Senseonics Holdings Overview
  • 11.10.3 Senseonics Holdings Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.10.4 Senseonics Holdings Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Senseonics Holdings Recent Developments
• 11.11 SOOIL
  • 11.11.1 SOOIL Corporation Information
  • 11.11.2 SOOIL Overview
  • 11.11.3 SOOIL Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.11.4 SOOIL Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 SOOIL Recent Developments
• 11.12 Tandem Diabetes care
  • 11.12.1 Tandem Diabetes care Corporation Information
  • 11.12.2 Tandem Diabetes care Overview
  • 11.12.3 Tandem Diabetes care Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.12.4 Tandem Diabetes care Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Tandem Diabetes care Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Industry Chain Analysis
• 12.2 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Production Mode & Process
• 12.4 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales and Marketing
  • 12.4.1 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Channels
  • 12.4.2 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Distributors
• 12.5 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Industry Trends
• 13.2 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Drivers
• 13.3 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Challenges
• 13.4 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Restraints

14 Key Findings in The Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details

Summary:

Market Analysis and Insights: Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market
Due to the COVID-19 pandemic, the global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Insulin Pump accounting for % of the Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Child segment is altered to an % CAGR throughout this forecast period.
China Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) market size is valued at US$ million in 2021, while the US and Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) include Abbott Laboratories, Dexcom, GlySens Incorporated, Insulet Corp, Johnson & Johnson, Medtronic, Meiqi Medical Equipment, Microport and Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Market Segments
The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.
Segment by Type
Insulin Pump
Continuous Glucose Monitors (CGM)
Segment by Application
Child
Adult
Elderly
Consequence of Covid-19 Pandemic
The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) market back to the pre-covid levels.
Trends & Prospects
In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Outlook
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Abbott Laboratories
Dexcom
GlySens Incorporated
Insulet Corp
Johnson & Johnson
Medtronic
Meiqi Medical Equipment
Microport
Roche
Senseonics Holdings
SOOIL
Tandem Diabetes care
Frequently Asked Questions
Which is the most lucrative product segment in the Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) market?
Which are the prominent strategies of the Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) market players?
Which factors are increasing the competition in the Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) market?
Which are the recommendations provided by the Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) industry experts?
Which region will witness rewarding growth during the forecast period?
What factors will curb the Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) market growth?
Which product segment will register the fastest growth rate in the Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) market?
Which emerging trends will impact the Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) market growth?
Which are the high-impact rendering factors in the Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) market?
Which companies will maintain their lead on the Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) market?